Shanghai Runda to revise articles, boost subsidiary guarantees

Shanghai Runda Medical Technology Co., Ltd. is set to hold its first extraordinary general meeting of shareholders in 2025 on September 12 to address key corporate governance and financial matters. The agenda includes the cancellation of the supervisory board, with its functions transferred to the board of directors' audit committee, and a comprehensive revision of the company's articles of association and various internal regulations. Additionally, shareholders will vote on the re-appointment of the company's accounting firm for 2025.

In parallel, the company disclosed a series of guarantees for its subsidiaries in August 2025, totaling 251,643.25 million yuan, which represents 117.60% of the company's net assets as of December 31, 2024. These guarantees, including 12,455 million yuan for Hangzhou Runda Medical Management and 1,000 million yuan for Shanghai Runyi Medical Scientific Instruments, are designed to support the subsidiaries' operational and development needs. The board approved these measures to enhance the subsidiaries' profitability and mitigate risks through continuous monitoring of cash flows and financial conditions.